[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cardiac Biomarkers Testing Market (2019-2025)

June 2019 | 250 pages | ID: GFCE940AA19EN
KBV Research

US$ 3,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period.

Cardiac biomarkers or cardiac markers are endogenous substances which are released in the blood stream when the heart is damaged or stressed. The acute coronary syndrome is caused by a plaque formed due to atherosclerosis, which causes thrombus formation in the damaged coronary artery and results in a sudden decrease in the amount of blood and oxygen which reaches the heart. Angina is due to the reduced blood supply in the heart, and when such blood flow is interrupted for 30–60 min, it can cause necrosis of heart muscle, resulting in myocardial infarction.

The recent product launches and further developments in the products are major growth trends which are providing lucrative growth opportunities to the cardiac biomarker market. The rising demand for efficient and rapid diagnostics of cardiovascular diseases is the key contributing factor to sector growth. Alere triage panel, manufactured by Alere, Inc., is a combination of three major biomarkers namely, CK-MB, myoglobin, and troponin I. The test is handy due to efficient detection of the cardiovascular disease and, being a combination product, there is a great demand for the test in the market.

Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. The PoC testing segment is projected to witness growth at the highest CAGR during the forecast period. The rising demand for the PoC segment has led to the growth of the segment. Moreover, the rising awareness in the developing countries regarding the use of PoC testing and its application in cardiac biomarkers has nurtured the market growth. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.

Scope of the Study

Market Segmentation:

By Type
  • Creatine Kinase (CK-MB)
  • Troponins
  • Myoglobin
  • Natriuretic Peptides (BNP and NT-proBNP)
  • Ischemia Modified Albumin
  • Others
By Application
  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others
By Location of Testing
  • Point of Care Testing
  • Laboratory Testing
By Geography
  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA
Companies Profiled
  • Trivitron Healthcare Pvt. Ltd.
  • Abbott Laboratories
  • Siemens AG
  • Becton, Dickinson AND Company
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Limited
  • Danaher Corporation
      • Thermo Fisher Scientific, Inc.
  • Johnson and Johnson
  • Quidel Corporation
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Global Cardiac Biomarkers Testing Market, by Type
  1.4.2 Global Cardiac Biomarkers Testing Market, by Application
  1.4.3 Global Cardiac Biomarkers Testing Market, by Location of Testing
  1.4.4 Global Cardiac Biomarkers Testing Market, by Geography
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Executive Summary
  2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraint

CHAPTER 3. GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY TYPE

  3.1.1 Global Creatine Kinase (CK-MB) Market by Region
  3.1.2 Global Troponins Market by Region
  3.1.3 Global Myoglobin Market by Region
  3.1.4 Global Natriuretic Peptides (BNP and NT-proBNP) Market by Region
  3.1.5 Global Ischemia Modified Albumin Market by Region
  3.1.6 Global Others Market by Region

CHAPTER 4. GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION

  4.1.1 Global Myocardial Infarction Market by Region
  4.1.2 Global Congestive Heart Failure Market by Region
  4.1.3 Global Acute Coronary Syndrome Market by Region
  4.1.4 Global Atherosclerosis Market by Region
  4.1.5 Global Others Market by Region

CHAPTER 5. GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING

  5.1.1 Global Point of Care Testing Market by Region
  5.1.2 Global Laboratory Testing Market by Region

CHAPTER 6. GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY REGION

6.1 North America Cardiac Biomarkers Testing Market
  6.1.1 North America Cardiac Biomarkers Testing Market by Type
    6.1.1.1 North America Creatine Kinase (CK-MB) Market by Country
    6.1.1.2 North America Troponins Market by Country
    6.1.1.3 North America Myoglobin Market by Country
    6.1.1.4 North America Natriuretic Peptides (BNP and NT-proBNP) Market by Country
    6.1.1.5 North America Ischemia Modified Albumin Market by Country
    6.1.1.6 North America Others Market by Country
  6.1.2 North America Cardiac Biomarkers Testing Market by Application
    6.1.2.1 North America Myocardial Infarction Market by Country
    6.1.2.2 North America Congestive Heart Failure Market by Country
    6.1.2.3 North America Acute Coronary Syndrome Market by Country
    6.1.2.4 North America Atherosclerosis Market by Country
    6.1.2.5 North America Others Market by Country
  6.1.3 North America Cardiac Biomarkers Testing Market by Location of Testing
    6.1.3.1 North America Point of Care Testing Market by Country
    6.1.3.2 North America Laboratory Testing Market by Country
  6.1.4 North America Cardiac Biomarkers Testing Market by Country
    6.1.4.1 USA Cardiac Biomarkers Testing Market
      6.1.4.1.1 USA Cardiac Biomarkers Testing Market by Type
      6.1.4.1.2 USA Cardiac Biomarkers Testing Market by Application
      6.1.4.1.3 USA Cardiac Biomarkers Testing Market by Location of Testing
    6.1.4.2 Canada Cardiac Biomarkers Testing Market
      6.1.4.2.1 Canada Cardiac Biomarkers Testing Market by Type
      6.1.4.2.2 Canada Cardiac Biomarkers Testing Market by Application
      6.1.4.2.3 Canada Cardiac Biomarkers Testing Market by Location of Testing
    6.1.4.3 Mexico Cardiac Biomarkers Testing Market
      6.1.4.3.1 Mexico Cardiac Biomarkers Testing Market by Type
      6.1.4.3.2 Mexico Cardiac Biomarkers Testing Market by Application
      6.1.4.3.3 Mexico Cardiac Biomarkers Testing Market by Location of Testing
    6.1.4.4 Rest of North America Cardiac Biomarkers Testing Market
      6.1.4.4.1 Rest of North America Cardiac Biomarkers Testing Market by Type
      6.1.4.4.2 Rest of North America Cardiac Biomarkers Testing Market by Application
      6.1.4.4.3 Rest of North America Cardiac Biomarkers Testing Market by Location of Testing
6.2 Europe Cardiac Biomarkers Testing Market
  6.2.1 Europe Cardiac Biomarkers Testing Market by Type
    6.2.1.1 Europe Creatine Kinase (CK-MB) Market by Country
    6.2.1.2 Europe Troponins Market by Country
    6.2.1.3 Europe Myoglobin Market by Country
    6.2.1.4 Europe Natriuretic Peptides (BNP and NT-proBNP) Market by Country
    6.2.1.5 Europe Ischemia Modified Albumin Market by Country
    6.2.1.6 Europe Others Market by Country
  6.2.2 Europe Cardiac Biomarkers Testing Market by Application
    6.2.2.1 Europe Myocardial Infarction Market by Country
    6.2.2.2 Europe Congestive Heart Failure Market by Country
    6.2.2.3 Europe Acute Coronary Syndrome Market by Country
    6.2.2.4 Europe Atherosclerosis Market by Country
    6.2.2.5 Europe Others Market by Country
  6.2.3 Europe Cardiac Biomarkers Testing Market by Location of Testing
    6.2.3.1 Europe Point of Care Testing Market by Country
    6.2.3.2 Europe Laboratory Testing Market by Country
  6.2.4 Europe Cardiac Biomarkers Testing Market by Country
    6.2.4.1 Germany Cardiac Biomarkers Testing Market
      6.2.4.1.1 Germany Cardiac Biomarkers Testing Market by Type
      6.2.4.1.2 Germany Cardiac Biomarkers Testing Market by Application
      6.2.4.1.3 Germany Cardiac Biomarkers Testing Market by Location of Testing
    6.2.4.2 UK Cardiac Biomarkers Testing Market
      6.2.4.2.1 UK Cardiac Biomarkers Testing Market by Type
      6.2.4.2.2 UK Cardiac Biomarkers Testing Market by Application
      6.2.4.2.3 UK Cardiac Biomarkers Testing Market by Location of Testing
    6.2.4.3 France Cardiac Biomarkers Testing Market
      6.2.4.3.1 France Cardiac Biomarkers Testing Market by Type
      6.2.4.3.2 France Cardiac Biomarkers Testing Market by Application
      6.2.4.3.3 France Cardiac Biomarkers Testing Market by Location of Testing
    6.2.4.4 Russia Cardiac Biomarkers Testing Market
      6.2.4.4.1 Russia Cardiac Biomarkers Testing Market by Type
      6.2.4.4.2 Russia Cardiac Biomarkers Testing Market by Application
      6.2.4.4.3 Russia Cardiac Biomarkers Testing Market by Location of Testing
    6.2.4.5 Spain Cardiac Biomarkers Testing Market
      6.2.4.5.1 Spain Cardiac Biomarkers Testing Market by Type
      6.2.4.5.2 Spain Cardiac Biomarkers Testing Market by Application
      6.2.4.5.3 Spain Cardiac Biomarkers Testing Market by Location of Testing
    6.2.4.6 Italy Cardiac Biomarkers Testing Market
      6.2.4.6.1 Italy Cardiac Biomarkers Testing Market by Type
      6.2.4.6.2 Italy Cardiac Biomarkers Testing Market by Application
      6.2.4.6.3 Italy Cardiac Biomarkers Testing Market by Location of Testing
    6.2.4.7 Rest of Europe Cardiac Biomarkers Testing Market
      6.2.4.7.1 Rest of Europe Cardiac Biomarkers Testing Market by Type
      6.2.4.7.2 Rest of Europe Cardiac Biomarkers Testing Market by Application
      6.2.4.7.3 Rest of Europe Cardiac Biomarkers Testing Market by Location of Testing
6.3 Asia Pacific Cardiac Biomarkers Testing Market
  6.3.1 Asia Pacific Cardiac Biomarkers Testing Market by Type
    6.3.1.1 Asia Pacific Creatine Kinase (CK-MB) Market by Country
    6.3.1.2 Asia Pacific Troponins Market by Country
    6.3.1.3 Asia Pacific Myoglobin Market by Country
    6.3.1.4 Asia Pacific Natriuretic Peptides (BNP and NT-proBNP) Market by Country
    6.3.1.5 Asia Pacific Ischemia Modified Albumin Market by Country
    6.3.1.6 Asia Pacific Others Market by Country
  6.3.2 Asia Pacific Cardiac Biomarkers Testing Market by Application
    6.3.2.1 Asia Pacific Myocardial Infarction Market by Country
    6.3.2.2 Asia Pacific Congestive Heart Failure Market by Country
    6.3.2.3 Asia Pacific Acute Coronary Syndrome Market by Country
    6.3.2.4 Asia Pacific Atherosclerosis Market by Country
    6.3.2.5 Asia Pacific Others Market by Country
  6.3.3 Asia Pacific Cardiac Biomarkers Testing Market by Location of Testing
    6.3.3.1 Asia Pacific Point of Care Testing Market by Country
    6.3.3.2 Asia Pacific Laboratory Testing Market by Country
  6.3.4 Asia Pacific Cardiac Biomarkers Testing Market by Country
    6.3.4.1 China Cardiac Biomarkers Testing Market
      6.3.4.1.1 China Cardiac Biomarkers Testing Market by Type
      6.3.4.1.2 China Cardiac Biomarkers Testing Market by Application
      6.3.4.1.3 China Cardiac Biomarkers Testing Market by Location of Testing
    6.3.4.2 Japan Cardiac Biomarkers Testing Market
      6.3.4.2.1 Japan Cardiac Biomarkers Testing Market by Type
      6.3.4.2.2 Japan Cardiac Biomarkers Testing Market by Application
      6.3.4.2.3 Japan Cardiac Biomarkers Testing Market by Location of Testing
    6.3.4.3 India Cardiac Biomarkers Testing Market
      6.3.4.3.1 India Cardiac Biomarkers Testing Market by Type
      6.3.4.3.2 India Cardiac Biomarkers Testing Market by Application
      6.3.4.3.3 India Cardiac Biomarkers Testing Market by Location of Testing
    6.3.4.4 South Korea Cardiac Biomarkers Testing Market
      6.3.4.4.1 South Korea Cardiac Biomarkers Testing Market by Type
      6.3.4.4.2 South Korea Cardiac Biomarkers Testing Market by Application
      6.3.4.4.3 South Korea Cardiac Biomarkers Testing Market by Location of Testing
    6.3.4.5 Singapore Cardiac Biomarkers Testing Market
      6.3.4.5.1 Singapore Cardiac Biomarkers Testing Market by Type
      6.3.4.5.2 Singapore Cardiac Biomarkers Testing Market by Application
      6.3.4.5.3 Singapore Cardiac Biomarkers Testing Market by Location of Testing
    6.3.4.6 Malaysia Cardiac Biomarkers Testing Market
      6.3.4.6.1 Malaysia Cardiac Biomarkers Testing Market by Type
      6.3.4.6.2 Malaysia Cardiac Biomarkers Testing Market by Application
      6.3.4.6.3 Malaysia Cardiac Biomarkers Testing Market by Location of Testing
    6.3.4.7 Rest of Asia Pacific Cardiac Biomarkers Testing Market
      6.3.4.7.1 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Type
      6.3.4.7.2 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Application
      6.3.4.7.3 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Location of Testing
6.4 LAMEA Cardiac Biomarkers Testing Market
  6.4.1 LAMEA Cardiac Biomarkers Testing Market by Type
    6.4.1.1 LAMEA Creatine Kinase (CK-MB) Market by Country
    6.4.1.2 LAMEA Troponins Market by Country
    6.4.1.3 LAMEA Myoglobin Market by Country
    6.4.1.4 LAMEA Natriuretic Peptides (BNP and NT-proBNP) Market by Country
    6.4.1.5 LAMEA Ischemia Modified Albumin Market by Country
    6.4.1.6 LAMEA Others Market by Country
  6.4.2 LAMEA Cardiac Biomarkers Testing Market by Application
    6.4.2.1 LAMEA Myocardial Infarction Market by Country
    6.4.2.2 LAMEA Congestive Heart Failure Market by Country
    6.4.2.3 LAMEA Acute Coronary Syndrome Market by Country
    6.4.2.4 LAMEA Atherosclerosis Market by Country
    6.4.2.5 LAMEA Others Market by Country
  6.4.3 LAMEA Cardiac Biomarkers Testing Market by Location of Testing
    6.4.3.1 LAMEA Point of Care Testing Market by Country
    6.4.3.2 LAMEA Laboratory Testing Market by Country
  6.4.4 LAMEA Cardiac Biomarkers Testing Market by Country
    6.4.4.1 Brazil Cardiac Biomarkers Testing Market
      6.4.4.1.1 Brazil Cardiac Biomarkers Testing Market by Type
      6.4.4.1.2 Brazil Cardiac Biomarkers Testing Market by Application
      6.4.4.1.3 Brazil Cardiac Biomarkers Testing Market by Location of Testing
    6.4.4.2 Argentina Cardiac Biomarkers Testing Market
      6.4.4.2.1 Argentina Cardiac Biomarkers Testing Market by Type
      6.4.4.2.2 Argentina Cardiac Biomarkers Testing Market by Application
      6.4.4.2.3 Argentina Cardiac Biomarkers Testing Market by Location of Testing
    6.4.4.3 UAE Cardiac Biomarkers Testing Market
      6.4.4.3.1 UAE Cardiac Biomarkers Testing Market by Type
      6.4.4.3.2 UAE Cardiac Biomarkers Testing Market by Application
      6.4.4.3.3 UAE Cardiac Biomarkers Testing Market by Location of Testing
    6.4.4.4 Saudi Arabia Cardiac Biomarkers Testing Market
      6.4.4.4.1 Saudi Arabia Cardiac Biomarkers Testing Market by Type
      6.4.4.4.2 Saudi Arabia Cardiac Biomarkers Testing Market by Application
      6.4.4.4.3 Saudi Arabia Cardiac Biomarkers Testing Market by Location of Testing
    6.4.4.5 South Africa Cardiac Biomarkers Testing Market
      6.4.4.5.1 South Africa Cardiac Biomarkers Testing Market by Type
      6.4.4.5.2 South Africa Cardiac Biomarkers Testing Market by Application
      6.4.4.5.3 South Africa Cardiac Biomarkers Testing Market by Location of Testing
    6.4.4.6 Nigeria Cardiac Biomarkers Testing Market
      6.4.4.6.1 Nigeria Cardiac Biomarkers Testing Market by Type
      6.4.4.6.2 Nigeria Cardiac Biomarkers Testing Market by Application
      6.4.4.6.3 Nigeria Cardiac Biomarkers Testing Market by Location of Testing
    6.4.4.7 Rest of LAMEA Cardiac Biomarkers Testing Market
      6.4.4.7.1 Rest of LAMEA Cardiac Biomarkers Testing Market by Type
      6.4.4.7.2 Rest of LAMEA Cardiac Biomarkers Testing Market by Application
      6.4.4.7.3 Rest of LAMEA Cardiac Biomarkers Testing Market by Location of Testing

CHAPTER 7. COMPANY PROFILES

7.1 Trivitron Healthcare Pvt. Ltd.
  7.1.1 Company Overview
  7.1.2 Recent strategies and developments:
    7.1.2.1 Collaborations, partnerships and agreements:
    7.1.2.2 Expansion:
7.2 ABBOTT Laboratories
  7.2.1 Company Overview
  7.2.2 Financial Analysis
  7.2.3 Segmental and Regional Analysis
  7.2.4 Research & Development Expense
  7.2.1 Recent strategies and developments:
    7.2.1.1 Acquisition and mergers:
    7.2.1.2 Product launches:
    7.2.1.3 Approvals:
  7.2.2 SWOT Analysis
7.3 Siemens AG (Siemens Healthineers, Inc.)
  7.3.1 Company Overview
  7.3.2 Financial Analysis
  7.3.3 Segmental and Regional Analysis
  7.3.4 Research & Development Expense
  7.3.5 Recent strategies and developments:
    7.3.5.1 Collaborations, partnerships and agreements:
    7.3.5.2 Product launches:
  7.3.6 SWOT Analysis
7.4 Becton, Dickinson and Company
  7.4.1 Company Overview
  7.4.2 Financial Analysis
  7.4.3 Segmental and Regional Analysis
  7.4.4 Research & Development Expense
  7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
  7.5.1 Company Overview
  7.5.2 Financial Analysis
  7.5.3 Segmental and Regional Analysis
  7.5.4 Research & Development Expenses
  7.5.5 Recent strategies and developments:
    7.5.5.1 Acquisition and mergers:
7.6 Randox Laboratories Limited
  7.6.1 Company Overview
  7.6.2 Recent strategies and developments:
    7.6.2.1 Collaborations, partnerships and agreements:
7.7 Danaher Corporation (Beckman Coulter, Inc.)
  7.7.1 Company Overview
  7.7.2 Financial Analysis
  7.7.3 Segmental and Regional Analysis
  7.7.4 Research & Development Expense
  7.7.5 Recent strategies and developments:
    7.7.5.1 Collaborations, partnerships and agreements:
    7.7.5.2 Approvals:
  7.7.6 SWOT Analysis
7.8 Thermo Fischer Scientific, Inc.
  7.8.1 Company Overview
  7.8.2 Financial Analysis
  7.8.3 Segmental and Regional Analysis
  7.8.4 Research & Development Expense
  7.8.5 Recent strategies and developments:
    7.8.5.1 Acquisition and mergers:
  7.8.6 SWOT Analysis
7.9 Johnson and Johnson
  7.9.1 Company Overview
  7.9.2 Financial Analysis
  7.9.3 Segmental &Regional Analysis
  7.9.4 Research & Development Expenses
  7.9.5 Recent strategies and developments:
    7.9.5.1 Collaborations, partnerships and agreements:
    7.9.5.2 Acquisition and mergers:
  7.9.6 SWOT Analysis
7.1 Quidel Corporation
  7.10.1 Company Overview
  7.10.2 Financial Analysis
  7.10.3 Regional Analysis
  7.10.4 Research & Development Expenses

LIST OF TABLES

TABLE 1 GLOBAL CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 2 GLOBAL CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 3 GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 GLOBAL CREATINE KINASE (CK-MB) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 6 GLOBAL CREATINE KINASE (CK-MB) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 7 GLOBAL TROPONINS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 8 GLOBAL TROPONINS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 9 GLOBAL MYOGLOBIN MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 10 GLOBAL MYOGLOBIN MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 11 GLOBAL NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 12 GLOBAL NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 13 GLOBAL ISCHEMIA MODIFIED ALBUMIN MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 14 GLOBAL ISCHEMIA MODIFIED ALBUMIN MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 15 GLOBAL OTHERS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 16 GLOBAL OTHERS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 17 GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 18 GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 19 GLOBAL MYOCARDIAL INFARCTION MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 20 GLOBAL MYOCARDIAL INFARCTION MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 21 GLOBAL CONGESTIVE HEART FAILURE MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 22 GLOBAL CONGESTIVE HEART FAILURE MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 23 GLOBAL ACUTE CORONARY SYNDROME MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 24 GLOBAL ACUTE CORONARY SYNDROME MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 25 GLOBAL ATHEROSCLEROSIS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 26 GLOBAL ATHEROSCLEROSIS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 27 GLOBAL OTHERS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 28 GLOBAL OTHERS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 29 GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 30 GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 31 GLOBAL POINT OF CARE TESTING MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 32 GLOBAL POINT OF CARE TESTING MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 33 GLOBAL LABORATORY TESTING MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 34 GLOBAL LABORATORY TESTING MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 35 GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 36 GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 37 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 38 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 39 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 NORTH AMERICA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 42 NORTH AMERICA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 43 NORTH AMERICA TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 44 NORTH AMERICA TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 45 NORTH AMERICA MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 46 NORTH AMERICA MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 47 NORTH AMERICA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 48 NORTH AMERICA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 49 NORTH AMERICA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 50 NORTH AMERICA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 51 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 52 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 53 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 54 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 55 NORTH AMERICA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 56 NORTH AMERICA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 57 NORTH AMERICA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 58 NORTH AMERICA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 59 NORTH AMERICA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 60 NORTH AMERICA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 61 NORTH AMERICA ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 62 NORTH AMERICA ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 63 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 64 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 65 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 66 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 67 NORTH AMERICA POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 68 NORTH AMERICA POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 69 NORTH AMERICA LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 70 NORTH AMERICA LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 71 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 72 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 73 USA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 74 USA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 75 USA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 76 USA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 77 USA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 78 USA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 79 USA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 80 USA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 81 CANADA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 82 CANADA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 83 CANADA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 84 CANADA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 85 CANADA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 86 CANADA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 87 CANADA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 88 CANADA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 89 MEXICO CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 90 MEXICO CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 91 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 92 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 93 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 94 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 95 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 96 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 97 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 98 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 99 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 100 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 101 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 102 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 103 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 104 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 105 EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 106 EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 107 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 108 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 109 EUROPE CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 110 EUROPE CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 111 EUROPE TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 112 EUROPE TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 113 EUROPE MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 114 EUROPE MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 115 EUROPE NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 116 EUROPE NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 117 EUROPE ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 118 EUROPE ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 119 EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 120 EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 121 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 122 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 123 EUROPE MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 124 EUROPE MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 125 EUROPE CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 126 EUROPE CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 127 EUROPE ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 128 EUROPE ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 129 EUROPE ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 130 EUROPE ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 131 EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 132 EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 133 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 134 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 135 EUROPE POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 136 EUROPE POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 137 EUROPE LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 138 EUROPE LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 139 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 140 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 141 GERMANY CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 142 GERMANY CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 143 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 144 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 145 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 146 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 147 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 148 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 149 UK CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 150 UK CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 151 UK CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 152 UK CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 153 UK CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 154 UK CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 155 UK CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 156 UK CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 157 FRANCE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 158 FRANCE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 159 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 160 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 161 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 162 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 163 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 164 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 165 RUSSIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 166 RUSSIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 167 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 168 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 169 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 170 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 171 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 172 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 173 SPAIN CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 174 SPAIN CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 175 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 176 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 177 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 178 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 179 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 180 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 181 ITALY CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 182 ITALY CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 183 ITALY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 184 ITALY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 185 ITALY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 186 ITALY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 187 ITALY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 188 ITALY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 189 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 190 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 191 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 192 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 193 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 194 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 195 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 196 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 197 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 198 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 199 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 200 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 201 ASIA PACIFIC CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 202 ASIA PACIFIC CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 203 ASIA PACIFIC TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 204 ASIA PACIFIC TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 205 ASIA PACIFIC MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 206 ASIA PACIFIC MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 207 ASIA PACIFIC NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 208 ASIA PACIFIC NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 209 ASIA PACIFIC ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 210 ASIA PACIFIC ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 211 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 212 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 213 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 214 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 215 ASIA PACIFIC MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 216 ASIA PACIFIC MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 217 ASIA PACIFIC CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 218 ASIA PACIFIC CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 219 ASIA PACIFIC ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 220 ASIA PACIFIC ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 221 ASIA PACIFIC ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 222 ASIA PACIFIC ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 223 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 224 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 225 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 226 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 227 ASIA PACIFIC POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 228 ASIA PACIFIC POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 229 ASIA PACIFIC LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 230 ASIA PACIFIC LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 231 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 232 ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 233 CHINA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 234 CHINA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 235 CHINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 236 CHINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 237 CHINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 238 CHINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 239 CHINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 240 CHINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 241 JAPAN CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 242 JAPAN CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 243 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 244 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 245 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 246 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 247 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 248 JAPAN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 249 INDIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 250 INDIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 251 INDIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 252 INDIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 253 INDIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 254 INDIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 255 INDIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 256 INDIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 257 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 258 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 259 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 260 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 261 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 262 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 263 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 264 SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 265 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 266 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 267 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 268 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 269 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 270 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 271 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 272 SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 273 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 274 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 275 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 276 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 277 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 278 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 279 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 280 MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 281 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 282 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 283 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 284 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 285 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 286 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 287 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 288 REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 289 LAMEA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 290 LAMEA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 291 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 292 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 293 LAMEA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 294 LAMEA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 295 LAMEA TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 296 LAMEA TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 297 LAMEA MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 298 LAMEA MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 299 LAMEA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 300 LAMEA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 301 LAMEA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 302 LAMEA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 303 LAMEA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 304 LAMEA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 305 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 306 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 307 LAMEA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 308 LAMEA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 309 LAMEA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 310 LAMEA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 311 LAMEA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 312 LAMEA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 313 LAMEA ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 314 LAMEA ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 315 LAMEA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 316 LAMEA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 317 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 318 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 319 LAMEA POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 320 LAMEA POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 321 LAMEA LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 322 LAMEA LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 323 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 324 LAMEA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 325 BRAZIL CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 326 BRAZIL CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 327 BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 328 BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 329 BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 330 BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 331 BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 332 BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 333 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 334 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 335 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 336 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 337 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 338 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 339 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 340 ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 341 UAE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 342 UAE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 343 UAE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 344 UAE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 345 UAE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 346 UAE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 347 UAE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 348 UAE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 349 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 350 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 351 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 352 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 353 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 354 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 355 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 356 SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 357 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 358 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 359 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 360 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 361 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 362 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 363 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 364 SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 365 NIGERIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 366 NIGERIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 367 NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 368 NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 369 NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 370 NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 371 NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 372 NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 373 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 374 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 375 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 376 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 377 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 378 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 379 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 380 REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 381 KEY INFORMATION – TRIVITRON HEALTHCARE PVT. LTD.
TABLE 382 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 383 KEY INFORMATION – SIEMENS AG
TABLE 384 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 385 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 386 KEY INFORMATION – RANDOX LABORATORIES LIMITED
TABLE 387 KEY INFORMATION – DANAHER CORPORATION
TABLE 388 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 389 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 390 KEY INFORMATION – QUIDEL CORPORATION

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 SWOT ANALYSIS: ABBOTT LABORATORIES
FIG 4 SWOT ANALYSIS: SIEMENS AG
FIG 5 SWOT ANALYSIS: BECTON, DICKINSON AND COMPANY
FIG 6 SWOT ANALYSIS: DANAHER CORPORATION
FIG 7 SWOT ANALYSIS: THERMO FISHER SCIENTIFIC, INC.
FIG 8 SWOT ANALYSIS: JOHNSON & JOHNSON


More Publications